The newest analgesics are far more specific than aspirin or narcotics, taking aim only at certain pain-causing cellular mechanisms.
ACTIQ Anesta
A crystallized narcotic on a stick, approved
in November, that offers quick relief for
breakthrough cancer pain.
CELEBREX, VIOXX Monsanto,
Merck
Arthritis treatments just reaching the market
that block pain and inflammation without the
stomach-damaging effects of aspirin-like
drugs.
NEURONTIN Warner-Lambert
An epilepsy drug in clinical trials for
chronic neuropathic pain. It targets a
neurotransmitter that controls both pain and
nerve excitability.
ZICONOTIDE Neurex
Based on the venom of a sea snail, it blocks
pain signals from entering the spinal cord.
Neurex will file for FDA approval this year.
MORPHIDEX Algos
Pharmaceutical
By blocking secondary pain sensors, the drug
allows morphine to be twice as effective
without increasing side effects. Algos filed
for FDA approval in August.
ABT-594 Abbott Laboratories
Based on a toxin in the skin of a rain-forest
frog, it prevents the central nervous system
from processing pain signals. In early human
trials.